These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
21. Hydralazine and beta-adrenergic blockade in the treatment of hypertension. Siitonen L; Jänne J; Keyriläinen O; Koskinen P; Leskinen O; Pitkäjärvi T; Reinikainen M Ann Clin Res; 1974 Dec; 6(6):341-6. PubMed ID: 4155933 [No Abstract] [Full Text] [Related]
22. Sympathomimetic and cardiodepressant effects of acebutolol, oxprenolol, pindolol, and propranolol. A comparative study on changes in hemodynamics, contractility, heart rate, and AV-conduction time at therapeutic doses. Gülker H; Kristek J; Heuer H; Bender F Arzneimittelforschung; 1981; 31(9):1416-22. PubMed ID: 6118162 [TBL] [Abstract][Full Text] [Related]
23. Pharmacodynamic studies of beta adrenergic antagonism induced in man by propranolol and practolol. Bodem G; Brammell HL; Weil JV; Chidsey CA J Clin Invest; 1973 Apr; 52(4):747-54. PubMed ID: 4144332 [TBL] [Abstract][Full Text] [Related]
24. Comparison of the effects on renin release of beta adrenergic antagonists with differing properties. Weber MA; Stokes GS; Gain JM J Clin Invest; 1974 Dec; 54(6):1413-9. PubMed ID: 4154950 [TBL] [Abstract][Full Text] [Related]
25. [Properties of beta-adrenergic receptors of heart and lung--studies with "cardioselective" beta-receptor blocking substances]. Krawietz W; Weinsteiger M; Pruchniewski M; Erdmann E Verh Dtsch Ges Kreislaufforsch; 1977; 43():414-5. PubMed ID: 26149 [No Abstract] [Full Text] [Related]
26. Selective beta adrenergic receptor antagonism in the anesthetized dog. Wasserman MA; Levy B J Pharmacol Exp Ther; 1974 Feb; 188(2):357-67. PubMed ID: 4149462 [No Abstract] [Full Text] [Related]
27. Effects of prolonged treatment with adrenergic beta-receptor antagonists on blood pressure, cardiovascular design and reactivity in spontaneously hypertensive rats (SHR). Weiss L; Lundgren Y; Folkow B Acta Physiol Scand; 1974 Aug; 91(4):447-57. PubMed ID: 4154700 [No Abstract] [Full Text] [Related]
28. Protection against isoprenaline induced myocardial necroses by beta-adrenergic blocking agents. Kulig A; Kostka-Trabka E; Gryglewski R Pol J Pharmacol Pharm; 1973; 25(1):85-90. PubMed ID: 4149575 [No Abstract] [Full Text] [Related]
29. [Effects of propranolol, practolol, trasicor and visken on cardiac chronotropism and supraventricular or ventricular arrhythmias]. Goch JH Pol Tyg Lek; 1972 Dec; 27(52):2049-51. PubMed ID: 4405621 [No Abstract] [Full Text] [Related]
30. Blockade of 5-hydroxytryptamine receptors in the central nervous system by beta-adrenoceptor antagonists. Weinstock M; Weiss C; Gitter S Neuropharmacology; 1977 Apr; 16(4):273-6. PubMed ID: 16230 [No Abstract] [Full Text] [Related]
31. The central action of drugs affecting beta-adrenergic receptor. IV. The influence of intraventricularly administered drugs affecting beta-adrenergic receptor on blood pressure in rats. Kleinrok Z; Ksiazek A Pol J Pharmacol Pharm; 1975; 27(2):177-82. PubMed ID: 239397 [TBL] [Abstract][Full Text] [Related]
32. Isoprenaline antagonism and duration of action in exercise induced tachycardia of three -adrenoceptor blocking drugs: pindolol, LF 17-895 and propranolol. Aellig WH Br J Pharmacol; 1973 Mar; 47(3):621P-622P. PubMed ID: 4147193 [No Abstract] [Full Text] [Related]
33. Pharmacological aspects of oxprenolol. Brunner H; Hedwall PR; Maier R; Meier M Postgrad Med J; 1970 Nov; ():Suppl:5-14. PubMed ID: 4395460 [No Abstract] [Full Text] [Related]
34. Comparison of the immediate effects of five beta-adrenoreceptor-blocking drugs with different ancillary properties in angina pectoris. Thadani U; Davidson C; Singleton W; Taylor SH N Engl J Med; 1979 Apr; 300(14):750-5. PubMed ID: 581782 [TBL] [Abstract][Full Text] [Related]
35. Effects of alpha- and beta-receptor blockade on systolic time intervals. Frei F; Imhof P; Dubach UC Eur J Clin Pharmacol; 1974; 7(1):1-10. PubMed ID: 4152857 [No Abstract] [Full Text] [Related]